BCC Excision Revisited

Long-term Results After Surgical Basal Cell Carcinoma Excision in the Eyelid Region: Revisited

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05853315

Enrollment

451

Registered

2023-05-10

Start date

2019-11-12

Completion date

2023-05-01

Last updated

2023-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal Cell Carcinoma, Eye Cancer, Eye Diseases

Brief summary

To readdress basal cell carcinoma (BCC) in the periocular region to prove histologically controlled surgical treatment efficacy and to identify high-risk characteristics.

Interventions

PROCEDURESurgery

Surgical Excision

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patient records were reviewed for the presence of BCC and surgical excision with frozen sections control of the wound margins in the periocular region, * conducted between 01.01.2009 and 31.12.2019. * Periocular was defined as the area involving the medial and lateral canthus as well as the upper and lower eyelids.

Exclusion criteria

* BCCs outside of this region were excluded from this analysis, * as well as incomplete records.

Design outcomes

Primary

Measure	Time frame
BCC Recurrence	mean 3-5 years

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026